Walmart to Begin Selling Biomerica’s Aware® Breast Self Exam
Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that under a General Merchandise Supplier Agreement with Walmart, the Company’s Aware® Breast Self Exam device will now be sold in Walmart’s retail system. Biomerica has now shipped its first orders of the Aware® product to Walmart, and Walmart will initially begin selling the product through its online sales channel in the USA,
Biomerica is also in the final phase of working with Walmart to stock and sell the Aware® product in Walmart stores in the U.S. Additionally, the Company is in negotiations with other partners for distribution of the Aware® Breast Self Exam product in markets outside of the U.S.
Breast Cancer is the most common cancer among women. Unfortunately, every woman is potentially at risk, as over 70% of women diagnosed have no family history of breast cancer. Currently, there is no way to prevent breast cancer, so detecting the disease early is key to effective treatment. Early detection significantly improves the chances that breast cancer can diagnosed and treated successfully. Survival rates are as high as 99% when the cancer is found early and is still localized in the breast. However, if the cancer has spread to the regional lymph nodes, the 5-year survival rate is 86%. [1,2]
About 80% of breast cancers are detected because women themselves notice changes in their breasts, highlighting the important role that each woman can play in her own health. However, a Breast Self Examination (BSE) is not a replacement for regular medical visits and periodic ultrasound or mammography. All three steps are important to finding breast cancer early. The relevance of early detection cannot be overemphasized.
